Introduction {#S1}
============

Adenomatoid tumors most commonly occur in the genital tract including the epididymis, uterus, or fallopian tube.^[@R1]^ Interestingly, these tumors have also been reported to occur in the adrenal gland.^[@R1]--[@R6]^ Adrenal adenomatoid tumors are derived from mesothelial cells from mesothelial rests within the adrenal gland. These rests are likely present due to the close embryological relationship between the adrenal glands and the Mullerian tract.^[@R6]--[@R7]^ This report represents the 29th case of an adrenal adenomatoid tumor in the literature, but is only the second case described in a patient with human immunodeficiency virus and the first case in which positron emission tomographic scanning was used as part of the diagnostic work-up.

Materials and Methods {#S2}
=====================

We describe the clinical course, laboratory, radiographic, and microscopic findings of a patient with human immunodeficiency virus and an adenomatoid tumor of the right adrenal gland. A review of the literature was also done via electronic searches through PubMed for articles from 1965 to 2008 that contained the following search terms, *adenomatoid tumor* limited to the English language only. All articles that contained reported cases of adenomatoid tumor were analyzed. Pertinent references from these articles were reviewed and synthesized. This cycle continued until it was felt that a complete listing of all published cases of adenomatoid tumors in the English language was obtained. This study was approved by the Institutional Review Board at University Hospitals of Cleveland.

Results {#S3}
=======

Report of a case
----------------

AH is a 22 year-old African-American male with a past medical history of human immunodeficiency virus on HAART (Highly Active Anti-Retroviral Therapy) who was noted to have an incidental adrenal mass on computed tomography of the chest done as a follow-up study for mediastinal lymphadenopathy. No previous adrenal masses were noted on previous computed tomographic imaging.

The patient denied any symptoms of palpitations, diaphoresis, flushing, or uncontrolled high blood pressure. He subsequently had a magnetic resonance imaging scan to further characterize the adrenal mass. It was a right adrenal mass that measured 2.7 by 1.6 by 2.3 cm in size with atypical enhancement patterns with gadolinium contrast. The patient underwent a complete adrenal hormonal work-up. His 24-hour urine catecholamines, serum aldosterone, and plasma renin activity were all normal. Serum cortisol level was mildly elevated, but his urinary cortisol level was normal. Prior to surgical referral, the patient also underwent a follow-up positron emission tomographic scan which demonstrated increased uptake of 3.4 SUV. Based on the above findings, the differential diagnosis included a non-functioning adrenal adenoma or malignancy. The patient underwent a laparoscopic right adrenalectomy with no post-operative complications on follow-up examination seven months later.

Pathologic findings
-------------------

On gross examination, the adrenal gland was 5.5 by 3.0 by 1.0 cm in size with a well-circumscribed, firm, tan-gray cortical mass that measured 2.5 by 2.5 by 1.0 cm. No areas of necrosis or hemorrhage were identified in the mass. On light microscopy examination, the adrenal mass was composed of epithelioid cells forming nests, cords, and tubules. There were no areas of necrosis, mitotic activity, or significant atypia. On immmunohistochemical examination, the cells in the adrenal mass were positive for calretinin and cytokeratins (AE1/3 and CAM 5.2) and negative for CD31, CD34, and Factor VIII. These morphological and immunohistochemical features were consistent with an adenomatoid tumor ([Figures 1](#F1){ref-type="fig"}--[3](#F3){ref-type="fig"}).

Figure 1The tissue at far right in this image is normal adrenal cortical tissue. The native adrenal tissue is replaced or extensively infiltrated by tumor cells forming small solid nests as well as anastomosing channels and tubules of variable size and shape.

Figure 2Lesional cells range from plump epithelioid cells to flattened cells resembling endothelial cells, and many exhibit prominent vacuolization, to an extent that may mimic a signet-ring appearance with apparent intracytoplasmic lumina. They do not exhibit nuclear pleomorphism, necrosis or mitotic activity.

Figure 3Immunostain for calretinin highlights the tumor cells, in keeping with their mesothelial derivation.

Literature review
-----------------

As illustrated in [Table 1](#T1){ref-type="table"} and [Table 2](#T2){ref-type="table"}, there have been 29 reported cases of adenomatoid tumors of the adrenal gland in the recent English-language medical literature.^[@R1]--[@R19]^ Almost all of these cases were in male patients (97%) with a mean age of 40Literature Review10 years (range=22--64). The laterality of these tumors is approximately 14 (48%) tumors on the right side and 14 (48%) tumors on the left side (laterality was unknown in one patient) with an average size of 4.6±4.0 cm (range=0.5--16.7 cm). Many of these tumors were either discovered as part of an autopsy or incidentally found as part of a diagnostic work-up for various symptoms including: painless hematuria, hypertension, abdominal pain, and Cushing\'s syndrome. Various imaging modalities were used including computed tomography (n=18), magnetic resonance imaging (n=6), ultrasound (n=3), and positron emission tomography (n=1). Interestingly, eight (31%) patients had adenomatoid tumors that extended into the periadrenal adipose tissue or the adrenal gland capsule. However, no recurrences have been reported with a median follow-up time of 33 months (range=3 to 177 months).

Table 1clinical data from review of the medical literature\#AuthorGenderAgeSide of massSize of mass (cm)Clinical dataCT SscanMRIU/SHormonal functionResectionFollow-up1Evans *et al.*MALE36LEFT11Painless hematuriaYNNAll WNLOPEN8 months2Simpson *et al.*MALE44LEFTNot statedHTNYNNElevated urinary\
homovanillic acid levelOPEN177 months3Travis *et al.*MALE24LEFT1.1Cushing syndromeNot statedNot statedNot statedNot statedOPENPatient expired 6\
months later secondary\
to massive pulmonary\
carcinoid metastases4Raaf *et al.*MALE49RIGHT1.3IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy5Raaf *et al.*MALE57LEFT3.8IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy6Raaf *et al.*FEMALE50RIGHT0.5IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy7Raaf *et al.*MALE40LEFT6IncidentalYNNNot statedNot statedNot stated8Angeles-Angeles *et al.*MALE34RIGHT3AIDSAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy9Gasque *et al.*MALE28RIGHT9Abdominal painNYYAll WNLNot stated16 months10Glatz *et al.*MALE54LEFT6.5Sudden epigastic painYNNNot statedNot statedNot stated11Chung-Park *et al.*MALE51RIGHT3HTNYNNLow plasma rennin\
activity and high aldosterone\
to plasma renin ratioLAPNot stated12Isotalo *et al.*MALE37LEFT3.1IncidentalNot statedNot statedNot statedNot statedNot stated40 months13Isotalo *et al.*MALE31RIGHT3.2IncidentalNot statedNot statedNot statedNot statedNot statedNot stated14Isotalo *et al.*MALE31Not stated3.5SyncopeNot statedNot statedNot statedNot statedNot stated50 months15Isotalo *et al.*MALE64LEFT1.2IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy16Kim and RoMALE33LEFT1.7HTNYNNNot statedNot statedNot stated17Denicol *et al.*MALE42LEFT14.3HTNYNYAll WNLOPEN3 years18Garg *et al.*MALE46RIGHT11Right flank painYNYNot doneOPENNot stated19Garg *et al.*MALE33LEFT1.7HTNYNNNot doneOPENNot stated20Garg *et al.*MALE33RIGHT4.2IncidentalYYNAll WNLOPEN1 year21Varkarakis *et al.*MALE54RIGHT3.6IncidentalYYNElevated urinary homovanillic acid levelLAP1 year22Hamamatsu *et al.*MALE30LEFT3IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy23Timonera *et al.*MALE47RIGHT5.6IncidentalYYNAll WNLLAPNot stated24MALE52RIGHT2HTNYYNAll WNLLAP25Fan *et al.*MALE42LEFT2.5HTNYNNAll WNLLAPNot stated26Hoffman *et al.*MALE26RIGHT1.5IncidentalYNNNot doneOPENNot stated27Bisceglia *et al.*MALE39RIGHT5.5IncidentalYNNAll WNLOPENNot stated28Liu *et al.*MALE44LEFT16.7IncidentalYNNAll WNLOPEN3 months29Phitayakorn *et al.*MALE22RIGHT2.5IncidentalYYNElevated serum cortisolLAP7 months

Table 2Pathological data from review of the medical literature.\# AuthorTumor characteristicsTumor extensionHistochemistryElectron microscopy1 Evans *et al.*Tan, smooth with cystic spacesNo extensionNot statedNumerous slender microvilli,\
desmoslome-like intracellular junctions,\
intracytoplasmic tonofilaments2 Simpson*et al.*Fleshy, gray, solid, cysticExtension into peri-adrenal\
adipose tissuePositive for antihuman cytokeratin,\
but negative for carcinoembryonic antigen;\
No glycogen or mucin contentNot done3 Travis *et al.*Pale, white, and solidExtension into cortex and periadrenal\
adipose tissueStrongly positive for keratin (AE1/AE3)\
and vimentin; Weakly positive for epithelial\
membrane antigenTortuous microvilli with a moderate\
amount of tonofilaments4 Raaf *et al.*White and solidNo extensionReacted with MAK-6 and AE1/AE3;\
Positive staining for vimentinLong, thin, bushy microvilli with well-\
developed desmosomes, basal laminae,\
and cytoplasmic tonofilaments5 Raaf *et al.*White, solid, firm, and smoothNo extensionReacted with MAK-6 and AE1/AE3;\
Positive staining for vimentinNot done6 Raaf *et al.*White, firm and smoothNo extensionNot statedNot done7 Raaf *et al.*White, predominantly cysticNo extensionReacted with MAK-6 and AE1/AE3;\
Positive staining for vimentin\
laminae, and cytoplasmic tonofilamentsLong, thin, bushy microvilli\
with well-developed desmosomes, basal8 Angeles-Angeles *et al.*Ill-defined, white-yellowish, and firm noduleNo extensionStained positive for low molecular weight\
cytokeratin CKAE-3 and weakly for vimentinNot done9 Gasque *et al.*Grayish with pseudocystNo extensionStains positive for cytokeratin (CAM 5.2)Not done10 Glatz *et al.*Pale-yellow, spongy, cysticNo extensionStrongly positive for keratin (Cam 5.2, Lu-5)\
and calretinin; Weakly positive\
for thrombomodulin.\
Negative staining for CEA, MOC-31, BerEP4,\
and CD34.Long and slender microvilli\
Long and slender microvilli\
and abundant desmosomes along\
luminal surface with bundles\
of tonofibrils in the cytoplasm11 Chung-Park *et al.*Pale-yellow, solid, and firmExtension into adrenal cortxPositive for cytokeratin and calretinin,\
but negative for synaptophysin,\
chromogranin,\
factor VIII, CD34, and S-100.Long, busy microvilli with\
intracytoplasmic tonofilaments,\
and intercellular desmosomes12 Isotalo *et al.*Solitary and poorly\
circumscribedExtension into peri-adrenal\
adipose tissueStrongly positive for calretinin, cytokeratins\
(AE1/AE3, CAM 5.2, CK7) and vimentin.\
Weakly positive for CK5/CK6.\
Negative for CD15, CD31, CD34, CK20,\
MOC31, and p-CEA.Not done13 Isotalo *et al.*Extension into adrenal gland capsuleNot done14 Isotalo *et al.*Extension into adrenal gland capsuleNot done15 Isotalo *et al.*Extension into peri-adrenal adipose tissueNot done16 Kim and RoSmooth, grayish, white and firm\
with cystic spacesNo extensionStained positive for cytokeratin\
and calretininDesmosomes. Cytomplasmic fibrillar\
networks, and numerous long, bushy,\
microvilli on luminal surfaces17 Denicol *et al.*Multicystic, yellow, opaqueNo extensionStains positive for AE1, AE3, and vimentinNot done18 Garg *et al.*Fibrous wall with an intramural\
well-demarcated tumor\
containing adipose tissue and\
lymphoidNo extensionStains positive for calretinin and focal weak\
staining for cytokeratin 5/6Numerous\
long, bushy, and slender microvilli19 Garg *et al.*Aggregates, areas of\
mucin production, cells with\
a signet ringlike appearanceNo extensionStains positive for calretinin\
and strong staining for cytokeratin 5/6Numerous\
long, bushy, and slender microvilli20 Garg *et al.*No extensionSains positive for calretininNot done21 Varkarakis *et al.*Tan nodular with sites\
of heterotopic ossificationNo extensionStains positive for calretininNot done22 Hamamatsu *et al.*White, solid, well-circumscribed,\
and smoothNo extensionStained positive for calretinin, D2--40,\
vimentin, and cytokeratins\
(AE1/AE3, OV-TL 12/30, CAM 5.2,\
and MNF116Not done23 Timonera *et al.*Well-circumscribed, solid,No extension\
with variegated yellow\
and tan cut surfaceStrongly positive for D2--40 and calretininNot done\
and weak reactivity for cytokeratin 5/624 Timonera *et al.*Well circumscribed,\
heterogeneous cystic and solid\
mass with hemorrhagic areas25 Fan *et al.*Ill-defined edge, smooth,\
greyish-white, firm, with\
no hemorrhage or necrosisFocal infiltration of adrenal\
cortex and medullaPositive for cytokeratin 7,\
calretinin, vimentin,\
antimesothelial cell ab,\
and epithelial membrane antigenNot done26 Hoffman *et al.*Grey-whitish pattern of small cystic\
nodules with trabeculaeNo extensionPositive for cytokeratin and calretinin,\
but negative for CD31, CD34, and CD56Not done27 Bisceglia *et al.*Cystic, gray to pale yellowish with slight\
mural thickening and short endoluminal\
papillationsNo extensionPositive to cytokeratins and calretinin,\
but negative to endothelial markersNumerous small microvilli\
(coelomic or mesothelial type)28 Liu *et al.*Ill-circumscribed multilocular cystic\
tumor with tan wall with no hemorrhage\
or necrosis, cyst fluid was clear-yellowEnveloped around the ipsilateral\
renal artery and veinPositive for calretinin and epithelial\
membrane antigen,\
but negative for endothelial markersNot done29 Phitayakorn *et al.*Well circumscribed, tan-gray\
cortical massNo extensionStained positive for calretinin and cytokeratins\
(AE1/AE3 and CAM 5.2), and stained\
negative for CD31, CD34, and factor VIII.Not done

In terms of tumor color, these tumors have been described as being white, tan, fleshy, pale-yellow, opaque, and grayish. In terms of tumor consistency, however, these tumors have been described as being firm, smooth, cystic, solid, and well-circumscribed. Other histopathological characteristics have been noted in adenomatoid tumors including: heterotopic ossification, lymphoid aggregates, sites of mucin production, and cells with a signet ring-like appearance.

Adenomatoid tumors have been found to stain positive with a wide variety of agents including: vimentin, calretinin, cytokeratins (CAM 5.2, CKAE1, and CKAE3), MAK-6, D2--40, OV-TL 12/30, and MNF 116. A few studies have examined adenomatoid tumors using electron microscopy and found various features including: numerous long, thin, bushy microvilli with well developed desmosomes, basal laminae, and cytoplasmic fibrillar networks.

Discussion {#S4}
==========

Patients with human immunodeficiency virus (HIV) frequently present with a number of associated neoplasms, often as a result of their immunosuppression. It is very unusual for HIV-positive patients to present with adrenal gland neoplasms other than Kaposi\'s sarcoma or lymphoma. HIV-positive patients may also present with infectious etiologies that may present as an adrenal mass, including cytomegalovirus necrotizing adrenalitis, mycobacterium, cryptococcus, or other fungal infections.^[@R20],[@R21]^ This case represents only the second reported case of an adenomatoid tumor in a patient with HIV. However, it is unknown how many other patients with reported adrenal adenomatoid tumors were tested for HIV. It is possible that the incidence of adrenal adenomatoid tumors in patients with HIV may increase as a consequence of anti-retroviral therapies or chronic immunosuppression.

Although the first adenomatoid tumor was described in 1945, adrenal adenomatoid tumors were not well described until the late 1980\'s.^[@R22]^ This result may be due to the increasing use of diagnostic computed tomographic imaging in detecting adrenal *incidentalomas*. This case also highlights an important caveat in that imaging techniques such as computed tomography cannot reliably distinguish adrenal adenomatoid tumors from other adrenocortical tumors.^[@R5]^ Magnetic resonance imaging of the adrenal adenomatoid tumor in this patient was more consistent with a functional adrenal tumor. Another study that used MRI in a patient with an adrenal adenomatoid noted that the tumor was mainly solid with cystic peripheral portions, and that the solid areas were homogenously isointense to the spleen on all images.^[@R5]^ In this particular case, the use of a positron-emission tomographic (PET) scan was also not helpful in pre-operatively diagnosing an adrenal adenomatoid tumor. In fact, the level of 18F-FDG uptake of 3.4 SUV was in the range of malignant adrenal lesions.^[@R23]^

Finally, this case emphasizes that although adrenal adenomatoid tumors have been described in the past as extending into the perirenal adipose tissue, the clinical behavior is definitely benign.^[@R10]^ Adrenal adenomatoid tumors may be misclassified as lymphangiomas or adenocarcinomas because of infiltrative borders into the adrenal capsule or periadrenal adipose tissue.^[@R24]^ These tumors can be reliably distinguished from adrenal adenocarcinoma as adenomatoid tumors stain positive for keratin and do not produce mucin. Based on [Table 1](#T1){ref-type="table"}, local resection limited to the adrenal gland itself without any specific post-operative surveillance protocol appears to be sufficient treatment of adrenal adenomatoid tumors. Laparoscopic adrenalectomy which is the current gold-standard for the surgical resection of adrenal tumors can be safely employed in the case of adrenal adenomatoid tumors.
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